Cencora

COR · NYSE

$343.27+$3.27 (+0.96%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $340.00

Latest news

NewsOct 8, 5:53 AM ET
Cencora Q3 2026 Earnings Call Transcript
Press releaseOct 2, 8:00 AM ETBusiness Wire
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
Press releaseSep 25, 8:00 AM ETBusiness Wire
Cencora Elects Robert E. Sanchez to Its Board of Directors
NewsAug 29, 12:01 AM ETMohd Haider
Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls Payout ‘Immaterial’
NewsAug 7, 9:37 AM ETPiero Cingari
Terrible Jobs Report Sparks Rally In AI and Tech: 10 Stocks Leading Friday's Surge
NewsAug 5, 12:44 PM ETVandana Singh
Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
NewsAug 5, 6:30 AM ET
Cencora Q3 Adj. EPS $4.48 Beats $4.35 Estimate, Sales $84.754B Beat $84.315B Estimate
Press releaseAug 5, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2026 Third Quarter Results
NewsAug 4, 1:51 PM ET
'FTC Takes Closer Look at Merger of Vet Products Distributors' - Bloomberg
Press releaseJul 1, 4:30 PM ETBusiness Wire
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
Press releaseJun 15, 4:15 PM ETBusiness Wire
Cencora Announces Samantha Hammock as Chief Human Resources Officer
NewsJun 3, 3:59 PM ETChris Katje
Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch
Press releaseMay 27, 6:55 AM ETBusiness Wire
Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
Press releaseMay 26, 5:43 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
Press releaseMay 21, 4:30 PM ETBusiness Wire
Cencora Announces Updated Fiscal Year 2026 Financial Outlook
Press releaseMay 19, 5:29 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
Press releaseMay 18, 2:53 PM ETGlobe Newswire
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm
Press releaseMay 15, 7:20 PM ETBusiness Wire
Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR
Press releaseMay 14, 10:25 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR
Press releaseMay 11, 12:00 PM ETBusiness Wire
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Press releaseMay 11, 9:00 AM ETBusiness Wire
Cencora, Inc. (COR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Press releaseMay 8, 5:26 PM ETBusiness Wire
Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
NewsMay 6, 2:49 PM ETVandana Singh
Why Is Cencora Stock Trading Lower On Wednesday?
NewsMay 6, 1:35 PM ETPiero Cingari
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
Press releaseMay 6, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2026 Second Quarter Results
Press releaseApr 1, 4:30 PM ETBusiness Wire
Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release
NewsMar 23, 7:11 AM ET
Cencora Agrees To Acquire EyeSouth Partners' Retina Business For $1.1B
Press releaseMar 23, 7:00 AM ETBusiness Wire
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business
NewsMar 17, 2:04 PM ETPiero Cingari
Trump Slams NATO, Energy Sector Rallies As Fuel Prices Spike: What's Moving Markets Tuesday?
Press releaseMar 17, 8:30 AM ETBusiness Wire
Cencora Announces Financial Leadership Transition
NewsFeb 18, 7:20 AM ET
Cencora Receives $1.25B Cash and 34.3% Stake in Covetrus-MWI Merger Worth $3.5B
Press releaseFeb 18, 7:00 AM ETBusiness Wire
Covetrus and MWI Animal Health to Merge
Press releaseFeb 13, 4:15 PM ETBusiness Wire
Cencora Closes $3.0 Billion Senior Notes Offering
Press releaseFeb 10, 5:15 PM ETBusiness Wire
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
Press releaseFeb 4, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2026 First Quarter Results
NewsDec 15, 9:09 AM ETVandana Singh
Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback
Press releaseDec 15, 7:00 AM ETBusiness Wire
Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
Press releaseNov 5, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results
Press releaseOct 16, 9:00 AM ETBusiness Wire
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
Press releaseAug 6, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2025 Third Quarter Results
Press releaseMay 7, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2025 Second Quarter Results
Press releaseFeb 5, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2025 First Quarter Results
Press releaseJan 27, 7:30 AM ETBusiness Wire
Harrow Partners with Cencora to Launch "Harrow Cares" Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients
Press releaseNov 6, 6:35 AM ETBusiness Wire
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
Press releaseJul 31, 6:30 AM ETBusiness Wire
Cencora Reports Fiscal 2024 Third Quarter Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Cencora Q3 2026 Earnings Call Transcript

Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release

Cencora Elects Robert E. Sanchez to Its Board of Directors

Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls Payout ‘Immaterial’

Terrible Jobs Report Sparks Rally In AI and Tech: 10 Stocks Leading Friday's Surge

Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins

Cencora Q3 Adj. EPS $4.48 Beats $4.35 Estimate, Sales $84.754B Beat $84.315B Estimate

Cencora Reports Fiscal 2026 Third Quarter Results

'FTC Takes Closer Look at Merger of Vet Products Distributors' - Bloomberg

Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release

Cencora Announces Samantha Hammock as Chief Human Resources Officer

Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch

Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

Cencora Announces Updated Fiscal Year 2026 Financial Outlook

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm

Rosen Law Firm Encourages Cencora, Inc. Investors to Inquire About Securities Class Action Investigation – COR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cencora, Inc. - COR

Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Cencora, Inc. (COR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Cencora, Inc. (COR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Why Is Cencora Stock Trading Lower On Wednesday?

S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today

Cencora Reports Fiscal 2026 Second Quarter Results

Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release

Cencora Agrees To Acquire EyeSouth Partners' Retina Business For $1.1B

Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business

Trump Slams NATO, Energy Sector Rallies As Fuel Prices Spike: What's Moving Markets Tuesday?

Cencora Announces Financial Leadership Transition

Cencora Receives $1.25B Cash and 34.3% Stake in Covetrus-MWI Merger Worth $3.5B

Covetrus and MWI Animal Health to Merge

Cencora Closes $3.0 Billion Senior Notes Offering

Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056

Cencora Reports Fiscal 2026 First Quarter Results

Cencora Strikes $5 Billion OneOncology Deal, Pauses Stock Buyback

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Cencora Reports Fiscal 2025 Third Quarter Results

Cencora Reports Fiscal 2025 Second Quarter Results

Cencora Reports Fiscal 2025 First Quarter Results

Harrow Partners with Cencora to Launch "Harrow Cares" Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Reports Fiscal 2024 Third Quarter Results